← All trials
NCT04767087
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 5, 2021
- Primary completion
- Feb 15, 2022
- Completion date
- Apr 15, 2022
- First posted
- Feb 23, 2021
- Last posted
- Jul 2, 2021
- Enrollment
- 1000
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Sheikh Zayed Medical CollegeLead sponsor
- Harvard UniversityStudy director
- King Edward Medical UniversityOverall official - principal investigator
- Sheikh Zayed Medical CollegeOverall official - principal investigator
- Sheikh Zayed Medical CollegeSponsor investigator
- University of Veterinary and Animal Sciences, LahoreStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.